LifeMD, Inc. LFMD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -6.50% | -3.55% | -1.42% | 3.84% | -10.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.50% | -3.55% | -1.42% | 3.84% | -10.41% |
| Cost of Revenue | 16.82% | -22.73% | -27.17% | -28.20% | 40.85% |
| Gross Profit | -10.55% | -0.43% | 3.48% | 11.15% | -15.73% |
| SG&A Expenses | -9.25% | 11.10% | 21.20% | -0.36% | -17.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 27.68% | 6.77% | 39.94% | 12.64% | 32.40% |
| Total Operating Expenses | -3.47% | 5.93% | 13.49% | -4.03% | -11.20% |
| Operating Income | -42.85% | -203.79% | -655.61% | 77.34% | 21.76% |
| Income Before Tax | 1.62% | -135.53% | -439.24% | 80.32% | 0.26% |
| Income Tax Expenses | -- | -- | -- | -97.68% | -86.32% |
| Earnings from Continuing Operations | 2.30% | -135.53% | -439.24% | 82.04% | 4.44% |
| Earnings from Discontinued Operations | -- | -- | -- | 1,373.96% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 106.64% | -292.66% |
| Net Income | -14.92% | -337.36% | -4,727.31% | 504.23% | 16.50% |
| EBIT | -42.85% | -203.79% | -655.61% | 77.34% | 21.76% |
| EBITDA | -45.46% | -216.82% | -744.14% | -154.87% | 21.04% |
| EPS Basic | -7.72% | -204.63% | -813.90% | 402.95% | 21.81% |
| Normalized Basic EPS | -13.06% | -72.44% | -223.48% | -- | 20.71% |
| EPS Diluted | -8.80% | -204.63% | -813.90% | 392.57% | 22.23% |
| Normalized Diluted EPS | -13.06% | -72.44% | -223.48% | -- | 20.71% |
| Average Basic Shares Outstanding | 4.37% | 7.63% | 9.74% | 10.82% | 9.86% |
| Average Diluted Shares Outstanding | 4.37% | 7.63% | 9.74% | 10.82% | 9.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.13% | 0.77% | 0.98% | -- | -0.20% |